Nickolay Kukekov - Feb 13, 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
Director
Signature
/s/ Nickolay Kukekov
Stock symbol
BRTX
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
2/15/2024, 04:23 PM
Previous filing
Feb 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRTX Stock Option Award $0 +79.6K $0.00 79.6K Feb 13, 2024 Common Stock 79.6K $1.45 Direct F3
holding BRTX Stock Option 25.2K Feb 13, 2024 Common Stock 25.2K $5.08 Direct F1
holding BRTX Stock Option 32K Feb 13, 2024 Common Stock 32K $2.91 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Nickolay Kukekov is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable to the extent of 12,618 shares on November 4, 2021 with the remaining 12,618 shares vesting quarterly in eight nearly equal installments beginning November 4, 2022 and continuing every three months thereafter until fully vested.
F2 The option vests and becomes exercisable in twelve monthly installments of 2,669 shares beginning on March 17, 2023 and continuing each month thereafter until fully vested.
F3 The option vests and becomes exercisable in twelve nearly equal monthly installments of 6,637 shares beginning on March 13, 2024 and continuing each month thereafter until fully vested.